Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 246

1.

Correction: Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population.

Rivas MA, Avila BE, Koskela J, Huang H, Stevens C, Pirinen M, Haritunians T, Neale BM, Kurki M, Ganna A, Graham D, Glaser B, Peter I, Atzmon G, Barzilai N, Levine AP, Schiff E, Pontikos N, Weisburd B, Lek M, Karczewski KJ, Bloom J, Minikel EV, Petersen BS, Beaugerie L, Seksik P, Cosnes J, Schreiber S, Bokemeyer B, Bethge J; International IBD Genetics Consortium; NIDDK IBD Genetics Consortium; T2D-GENES Consortium, Heap G, Ahmad T, Plagnol V, Segal AW, Targan S, Turner D, Saavalainen P, Farkkila M, Kontula K, Palotie A, Brant SR, Duerr RH, Silverberg MS, Rioux JD, Weersma RK, Franke A, Jostins L, Anderson CA, Barrett JC, MacArthur DG, Jalas C, Sokol H, Xavier RJ, Pulver A, Cho JH, McGovern DPB, Daly MJ.

PLoS Genet. 2019 May 30;15(5):e1008190. doi: 10.1371/journal.pgen.1008190. eCollection 2019 May.

2.

Nancy Index Scores of Chronic Inflammatory Bowel Disease Activity Associate With Development of Colorectal Neoplasia.

Kirchgesner J, Svrcek M, Le Gall G, Landman C, Dray X, Bourrier A, Nion-Larmurier I, Hoyeau N, Sokol H, Seksik P, Cosnes J, Fléjou JF, Beaugerie L; Saint-Antoine Inflammatory Bowel Disease Network.

Clin Gastroenterol Hepatol. 2019 May 11. pii: S1542-3565(19)30511-7. doi: 10.1016/j.cgh.2019.05.002. [Epub ahead of print]

PMID:
31085339
3.

Genetic effects on the commensal microbiota in inflammatory bowel disease patients.

Aschard H, Laville V, Tchetgen ET, Knights D, Imhann F, Seksik P, Zaitlen N, Silverberg MS, Cosnes J, Weersma RK, Xavier R, Beaugerie L, Skurnik D, Sokol H.

PLoS Genet. 2019 Mar 8;15(3):e1008018. doi: 10.1371/journal.pgen.1008018. eCollection 2019 Mar.

4.

Risk of serious infection in healthcare workers with inflammatory bowel disease: a case-control study of the Groupe d'Etude Thérapeutique des Affections Inflammatoires du tube Digestif (GETAID).

Gagnière C, Bourrier A, Seksik P, Gornet JM, DeWit O, Nancey S, Altwegg R, Abitbol V, Laharie D, Reenaers C, Buisson A, Pariente B, Viennot S, Vuitton L, Stefanescu C, Marteau P, Bouguen G, Cosnes J, Amiot A; GETAID INFOPRO study group.

Aliment Pharmacol Ther. 2018 Oct;48(7):713-722. doi: 10.1111/apt.14926. Epub 2018 Aug 2.

PMID:
30069921
5.

Insights into the genetic epidemiology of Crohn's and rare diseases in the Ashkenazi Jewish population.

Rivas MA, Avila BE, Koskela J, Huang H, Stevens C, Pirinen M, Haritunians T, Neale BM, Kurki M, Ganna A, Graham D, Glaser B, Peter I, Atzmon G, Barzilai N, Levine AP, Schiff E, Pontikos N, Weisburd B, Lek M, Karczewski KJ, Bloom J, Minikel EV, Petersen BS, Beaugerie L, Seksik P, Cosnes J, Schreiber S, Bokemeyer B, Bethge J; International IBD Genetics Consortium; NIDDK IBD Genetics Consortium; T2D-GENES Consortium, Heap G, Ahmad T, Plagnol V, Segal AW, Targan S, Turner D, Saavalainen P, Farkkila M, Kontula K, Palotie A, Brant SR, Duerr RH, Silverberg MS, Rioux JD, Weersma RK, Franke A, Jostins L, Anderson CA, Barrett JC, MacArthur DG, Jalas C, Sokol H, Xavier RJ, Pulver A, Cho JH, McGovern DPB, Daly MJ.

PLoS Genet. 2018 May 24;14(5):e1007329. doi: 10.1371/journal.pgen.1007329. eCollection 2018 May. Erratum in: PLoS Genet. 2019 May 30;15(5):e1008190.

6.

Comparing Inpatient Satisfaction Collected via a Web-Based Questionnaire Self-Completion and Through a Telephone Interview: An Ancillary Study of the SENTIPAT Randomized Controlled Trial.

Feldman SF, Lapidus N, Cosnes J, Tiret E, Fonquernie L, Cabane J, Chazouilleres O, Surgers L, Beaussier M, Valleron AJ, Carrat F, Hejblum G.

J Med Internet Res. 2017 Aug 23;19(8):e293. doi: 10.2196/jmir.7061.

7.

Specificities of the intestinal microbiota in patients with inflammatory bowel disease and Clostridium difficile infection.

Sokol H, Jegou S, McQuitty C, Straub M, Leducq V, Landman C, Kirchgesner J, Le Gall G, Bourrier A, Nion-Larmurier I, Cosnes J, Seksik P, Richard ML, Beaugerie L.

Gut Microbes. 2018 Jan 2;9(1):55-60. doi: 10.1080/19490976.2017.1361092. Epub 2017 Sep 21.

8.

[Crohn's disease and hidradenitis suppurativa: An announced crisis?]

Cohen L, Fathallah N, Pommaret E, de Parades V, Cosnes J.

Presse Med. 2017 Jul - Aug;46(7-8 Pt 1):777-778. doi: 10.1016/j.lpm.2017.05.008. Epub 2017 Jul 24. French. No abstract available.

PMID:
28751066
9.

Chronic diarrhea: diagnostic strategy

Nion-Larmurier I, Cosnes J.

Rev Prat. 2017 May;67(5):e246. French. No abstract available.

PMID:
30512689
10.

Chronic diarrhea

Nion-Larmurier I, Cosnes J.

Rev Prat. 2017 May;67(5):e239-e245. French. No abstract available.

PMID:
30512688
11.

Postoperative thiopurines in smokers with Crohn's disease.

Cosnes J.

Lancet Gastroenterol Hepatol. 2016 Dec;1(4):262-263. doi: 10.1016/S2468-1253(16)30115-7. Epub 2016 Nov 10. No abstract available.

12.

Risk of Rectal Neoplasia after Colectomy and Ileorectal Anastomosis for Ulcerative Colitis.

Uzzan M, Kirchgesner J, Oubaya N, Amiot A, Gornet JM, Seksik P, Nancey S, Cotte E, Allez M, Boschetti G, Laharie D, de Angelis N, Nachury M, Pelletier AL, Abitbol V, Fumery M, Brouquet A, Buisson A, Altwegg R, Cosnes J, Panis Y, Treton X.

J Crohns Colitis. 2017 Aug 1;11(8):930-935. doi: 10.1093/ecco-jcc/jjx027.

PMID:
28333202
13.

Clostridium difficile infection in acute flares of inflammatory bowel disease: A prospective study.

Sokol H, Lalande V, Landman C, Bourrier A, Nion-Larmurier I, Rajca S, Kirchgesner J, Seksik P, Cosnes J, Barbut F, Beaugerie L.

Dig Liver Dis. 2017 Jun;49(6):643-646. doi: 10.1016/j.dld.2017.01.162. Epub 2017 Jan 30.

PMID:
28215602
14.

What Should Be Done in Inflammatory Bowel Disease Patients with Prior Malignancy?

Cosnes J.

Dig Dis. 2017;35(1-2):50-55. doi: 10.1159/000449083. Epub 2017 Feb 1. Review.

PMID:
28147366
15.

Autoimmune cytopenias associated with inflammatory bowel diseases: Insights from a multicenter retrospective cohort.

Uzzan M, Galicier L, Gornet JM, Oksenhendler E, Fieschi C, Allez M, Bouhnik Y, Kirchgesner J, Boutboul D, Treton X, Gérard L, Mahévas M, Cosnes J, Amiot A.

Dig Liver Dis. 2017 Apr;49(4):397-404. doi: 10.1016/j.dld.2016.12.006. Epub 2016 Dec 23.

PMID:
28063954
16.

Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximab.

Laharie D, Bourreille A, Branche J, Allez M, Bouhnik Y, Filippi J, Zerbib F, Savoye G, Vuitton L, Moreau J, Amiot A, Cosnes J, Ricart E, Dewit O, Lopez-Sanroman A, Fumery M, Carbonnel F, Bommelaer G, Coffin B, Roblin X, van Assche G, Esteve M, Farkkila M, Gisbert JP, Marteau P, Nahon S, de Vos M, Lambert J, Mary JY, Louis E; Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.

Gut. 2018 Feb;67(2):237-243. doi: 10.1136/gutjnl-2016-313060. Epub 2017 Jan 4.

17.

Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease.

Mottet C, Schoepfer AM, Juillerat P, Cosnes J, Froehlich F, Kessler-Brondolo V, Seibold F, Rogler G, Vavricka SR, Michetti P.

Inflamm Bowel Dis. 2016 Nov;22(11):2733-2747.

18.

Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease.

Cosnes J, Sokol H, Bourrier A, Nion-Larmurier I, Wisniewski A, Landman C, Marteau P, Beaugerie L, Perez K, Seksik P.

Aliment Pharmacol Ther. 2016 Nov;44(10):1102-1113. doi: 10.1111/apt.13808. Epub 2016 Sep 26.

19.

Long-term Follow-up After Ileorectal Anastomosis for Ulcerative Colitis: A GETAID/GETAID Chirurgie Multicenter Retrospective Cohort of 343 Patients.

Uzzan M, Cosnes J, Amiot A, Gornet JM, Seksik P, Cotte E, Tiret E, Panis Y, Treton X.

Ann Surg. 2017 Dec;266(6):1029-1034. doi: 10.1097/SLA.0000000000002022.

PMID:
27655238
20.

Digestive-tract sarcoidosis: French nationwide case-control study of 25 cases.

Ghrenassia E, Mekinian A, Chapelon-Albric C, Levy P, Cosnes J, Sève P, Lefèvre G, Dhôte R, Launay D, Prendki V, Morell-Dubois S, Sadoun D, Mehdaoui A, Soussan M, Bourrier A, Ricard L, Benamouzig R, Valeyre D, Fain O; Groupe Sarcoïdose Francophone.

Medicine (Baltimore). 2016 Jul;95(29):e4279. doi: 10.1097/MD.0000000000004279.

21.

Endoscopic Detection of Small Bowel Dysplasia and Adenocarcinoma in Crohn's Disease: A Prospective Cohort-Study in High-Risk Patients.

Simon M, Cosnes J, Gornet JM, Seksik P, Stefanescu C, Blain A, Pariente B, Nancey S, Vuitton L, Nachury M, D'Haens G, Filippi J, Chevret S, Laharie D; GETAID group.

J Crohns Colitis. 2017 Jan;11(1):47-52. doi: 10.1093/ecco-jcc/jjw123. Epub 2016 Jul 12.

PMID:
27405958
22.

Negative Screening Does Not Rule Out the Risk of Tuberculosis in Patients with Inflammatory Bowel Disease Undergoing Anti-TNF Treatment: A Descriptive Study on the GETAID Cohort.

Abitbol Y, Laharie D, Cosnes J, Allez M, Nancey S, Amiot A, Aubourg A, Fumery M, Altwegg R, Michetti P, Chanteloup E, Seksik P, Baudry C, Flamant M, Bouguen G, Stefanescu C, Bourrier A, Bommelaer G, Dib N, Bigard MA, Viennot S, Hébuterne X, Gornet JM, Marteau P, Bouhnik Y, Abitbol V, Nahon S; GETAID.

J Crohns Colitis. 2016 Oct;10(10):1179-85. doi: 10.1093/ecco-jcc/jjw129. Epub 2016 Jul 11.

PMID:
27402916
23.

Impact on Life Expectancy of Withdrawing Thiopurines in Patients with Crohn's Disease in Sustained Clinical Remission: A Lifetime Risk-Benefit Analysis.

Kirchgesner J, Beaugerie L, Carrat F, Sokol H, Cosnes J, Schwarzinger M; BERENICE Study Group.

PLoS One. 2016 Jun 6;11(6):e0157191. doi: 10.1371/journal.pone.0157191. eCollection 2016.

24.

CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands.

Lamas B, Richard ML, Leducq V, Pham HP, Michel ML, Da Costa G, Bridonneau C, Jegou S, Hoffmann TW, Natividad JM, Brot L, Taleb S, Couturier-Maillard A, Nion-Larmurier I, Merabtene F, Seksik P, Bourrier A, Cosnes J, Ryffel B, Beaugerie L, Launay JM, Langella P, Xavier RJ, Sokol H.

Nat Med. 2016 Jun;22(6):598-605. doi: 10.1038/nm.4102. Epub 2016 May 9.

25.

[Smoking, smoking cessation and Crohn's disease].

Underner M, Perriot J, Cosnes J, Beau P, Peiffer G, Meurice JC.

Presse Med. 2016 Apr;45(4 Pt 1):390-402. doi: 10.1016/j.lpm.2016.02.008. Epub 2016 Mar 23. Review. French.

PMID:
27016849
26.

Smoking and Diet: Impact on Disease Course?

Cosnes J.

Dig Dis. 2016;34(1-2):72-7. doi: 10.1159/000442930. Epub 2016 Mar 16. Review.

PMID:
26981632
27.

Fungal microbiota dysbiosis in IBD.

Sokol H, Leducq V, Aschard H, Pham HP, Jegou S, Landman C, Cohen D, Liguori G, Bourrier A, Nion-Larmurier I, Cosnes J, Seksik P, Langella P, Skurnik D, Richard ML, Beaugerie L.

Gut. 2017 Jun;66(6):1039-1048. doi: 10.1136/gutjnl-2015-310746. Epub 2016 Feb 3.

28.

Azathioprine May Not be Associated With Development of Colorectal Tumors With Microsatellite Instability in Patients With Inflammatory Bowel Disease.

Svrcek M, Beaugerie L, Kirchgesner J, Dumont S, Muleris M, Bodo S, Dartigues P, Lascols O, Seksik P, Cosnes J, Fléjou JF, Duval A.

Am J Gastroenterol. 2016 Jan;111(1):149-51. doi: 10.1038/ajg.2015.406. No abstract available.

PMID:
26785668
29.

Long-term Outcomes of Thalidomide Therapy for Adults With Refractory Crohn's Disease.

Simon M, Pariente B, Lambert J, Cosnes J, Bouhnik Y, Marteau P, Allez M, Colombel JF, Gornet JM.

Clin Gastroenterol Hepatol. 2016 Jul;14(7):966-972.e2. doi: 10.1016/j.cgh.2015.10.034. Epub 2015 Nov 18.

PMID:
26598226
30.

Excess risk of urinary tract cancers in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study.

Bourrier A, Carrat F, Colombel JF, Bouvier AM, Abitbol V, Marteau P, Cosnes J, Simon T, Peyrin-Biroulet L, Beaugerie L; CESAME study group.

Aliment Pharmacol Ther. 2016 Jan;43(2):252-61. doi: 10.1111/apt.13466. Epub 2015 Nov 9.

31.

The outcome of infliximab dose doubling in 157 patients with ulcerative colitis after loss of response to infliximab.

Dumitrescu G, Amiot A, Seksik P, Baudry C, Stefanescu C, Gagniere C, Allez M, Cosnes J, Bouhnik Y.

Aliment Pharmacol Ther. 2015 Nov;42(10):1192-9. doi: 10.1111/apt.13393. Epub 2015 Sep 10.

32.

Systemic adalimumab induces peripheral corneal infiltrates: a case report.

Matet A, Daruich A, Beydoun T, Cosnes J, Bourges JL.

BMC Ophthalmol. 2015 Jun 6;15:57. doi: 10.1186/s12886-015-0047-6.

33.

Changes in the Lémann Index Values During the First Years of Crohn's Disease.

Gilletta C, Lewin M, Bourrier A, Nion-Larmurier I, Rajca S, Beaugerie L, Sokol H, Pariente B, Seksik P, Cosnes J.

Clin Gastroenterol Hepatol. 2015 Sep;13(9):1633-40.e3. doi: 10.1016/j.cgh.2015.02.041. Epub 2015 Mar 10.

PMID:
25766650
34.

Benefit of infliximab reintroduction after successive failure of infliximab and adalimumab in Crohn's disease.

Gagniere C, Beaugerie L, Pariente B, Seksik P, Amiot A, Abitbol V, Allez M, Cosnes J, Sokol H.

J Crohns Colitis. 2015 Apr;9(4):349-55. doi: 10.1093/ecco-jcc/jju024. Epub 2014 Dec 28.

PMID:
25547977
35.

Factors associated with durable response to infliximab in Crohn's disease 5 years and beyond: a multicenter international cohort.

Juillerat P, Sokol H, Froehlich F, Yajnik V, Beaugerie L, Lucci M, Burnand B, Macpherson AJ, Cosnes J, Korzenik JR.

Inflamm Bowel Dis. 2015 Jan;21(1):60-70. doi: 10.1097/MIB.0000000000000225.

PMID:
25517594
36.

Prevalence and risk factors of Clostridium difficile infection in patients hospitalized for flare of inflammatory bowel disease: a retrospective assessment.

Regnault H, Bourrier A, Lalande V, Nion-Larmurier I, Sokol H, Seksik P, Barbut F, Cosnes J, Beaugerie L.

Dig Liver Dis. 2014 Dec;46(12):1086-92. doi: 10.1016/j.dld.2014.09.003. Epub 2014 Oct 5.

PMID:
25294795
37.

Development of the Lémann index to assess digestive tract damage in patients with Crohn's disease.

Pariente B, Mary JY, Danese S, Chowers Y, De Cruz P, D'Haens G, Loftus EV Jr, Louis E, Panés J, Schölmerich J, Schreiber S, Vecchi M, Branche J, Bruining D, Fiorino G, Herzog M, Kamm MA, Klein A, Lewin M, Meunier P, Ordas I, Strauch U, Tontini GE, Zagdanski AM, Bonifacio C, Rimola J, Nachury M, Leroy C, Sandborn W, Colombel JF, Cosnes J.

Gastroenterology. 2015 Jan;148(1):52-63.e3. doi: 10.1053/j.gastro.2014.09.015. Epub 2014 Sep 21.

PMID:
25241327
38.

Long-term outcome of enterocutaneous fistula in patients with Crohn's disease treated with anti-TNF therapy: a cohort study from the GETAID.

Amiot A, Setakhr V, Seksik P, Allez M, Treton X, De Vos M, Laharie D, Colombel JF, Abitbol V, Reimund JM, Moreau J, Veyrac M, Flourié B, Cosnes J, Lemann M, Bouhnik Y.

Am J Gastroenterol. 2014 Sep;109(9):1443-9. doi: 10.1038/ajg.2014.183. Epub 2014 Aug 5.

PMID:
25091063
39.

Small bowel adenocarcinomas complicating Crohn's disease are associated with dysplasia: a pathological and molecular study.

Svrcek M, Piton G, Cosnes J, Beaugerie L, Vermeire S, Geboes K, Lemoine A, Cervera P, El-Murr N, Dumont S, Scriva A, Lascols O, Ardizzone S, Fociani P, Savoye G, Le Pessot F, Novacek G, Wrba F, Colombel JF, Leteurtre E, Bouhnik Y, Cazals-Hatem D, Cadiot G, Diebold MD, Rahier JF, Delos M, Fléjou JF, Carbonnel F.

Inflamm Bowel Dis. 2014 Sep;20(9):1584-92. doi: 10.1097/MIB.0000000000000112.

PMID:
25029614
40.

Complications and surgery in the inflammatory bowel diseases biological era.

Sokol H, Seksik P, Cosnes J.

Curr Opin Gastroenterol. 2014 Jul;30(4):378-84. doi: 10.1097/MOG.0000000000000078. Review.

PMID:
24840000
41.

The impact of cytomegalovirus reactivation and its treatment on the course of inflammatory bowel disease.

Delvincourt M, Lopez A, Pillet S, Bourrier A, Seksik P, Cosnes J, Carrat F, Gozlan J, Beaugerie L, Roblin X, Peyrin-Biroulet L, Sokol H.

Aliment Pharmacol Ther. 2014 Apr;39(7):712-20. doi: 10.1111/apt.12650. Epub 2014 Feb 9.

42.

Reply: To PMID 23644079.

Cosnes J, Colombel JF.

Gastroenterology. 2014 Mar;146(3):868-9. doi: 10.1053/j.gastro.2014.01.047. Epub 2014 Jan 24. No abstract available.

PMID:
24468181
43.

Impact of the diagnosis and treatment of cancer on the course of inflammatory bowel disease.

Rajca S, Seksik P, Bourrier A, Sokol H, Nion-Larmurier I, Beaugerie L, Cosnes J.

J Crohns Colitis. 2014 Aug;8(8):819-24. doi: 10.1016/j.crohns.2013.12.022. Epub 2014 Jan 16.

PMID:
24439392
44.

The causal representation of outpatients with Crohn's disease: is there a link between psychological distress and clinical disease activity?

Banovic I, Gilibert D, Andronikof A, Jebrane A, Ajdukovic I, Cosnes J.

Psychosoc Med. 2013 Dec 16;10:Doc08. doi: 10.3205/psm000098. eCollection 2013.

45.

Milder multiple sclerosis course in patients with concomitant inflammatory bowel disease.

Zéphir H, Gower-Rousseau C, Salleron J, Simon O, Debouverie M, Le Page E, Bouhnik Y, Lebrun-Frenay C, Papeix C, Vigneron B, Allez M, Prin L, Cosnes J, Vermersch P, Colombel JF; CFSEP, GETAID and EPIMAD Groups.

Mult Scler. 2014 Jul;20(8):1135-9. doi: 10.1177/1352458513515081. Epub 2013 Dec 10.

PMID:
24326672
46.

Cap polyposis and colitis cystica profunda: a rare association.

Arana R, Fléjou JF, Parc Y, El-Murr N, Cosnes J, Svrcek M.

Histopathology. 2014 Mar;64(4):604-7. doi: 10.1111/his.12292. Epub 2013 Nov 18. No abstract available.

PMID:
24118052
47.

Measuring structural damage in Crohn's disease.

Cosnes J.

Gastroenterol Hepatol (N Y). 2013 Feb;9(2):103-4. No abstract available.

48.

Early administration of azathioprine vs conventional management of Crohn's Disease: a randomized controlled trial.

Cosnes J, Bourrier A, Laharie D, Nahon S, Bouhnik Y, Carbonnel F, Allez M, Dupas JL, Reimund JM, Savoye G, Jouet P, Moreau J, Mary JY, Colombel JF; Groupe d'Etude Thérapeutique des Affections Inflammatoires du Tube Digestif (GETAID).

Gastroenterology. 2013 Oct;145(4):758-65.e2; quiz e14-5. doi: 10.1053/j.gastro.2013.04.048. Epub 2013 Apr 30.

PMID:
23644079
49.

Is there still a room for azathioprine monotherapy in inflammatory bowel disease?

Bourrier A, Seksik P, Cosnes J.

Curr Drug Targets. 2013 Nov;14(12):1471-9. Review.

PMID:
23574282
50.

Early azathioprine in Crohn's disease.

Cosnes J, Seksik P.

Inflamm Bowel Dis. 2013 Mar;19(3):674-5. doi: 10.1097/MIB.0b013e318281d697. No abstract available.

PMID:
23429451

Supplemental Content

Loading ...
Support Center